High density lipoprotein mimicking nanoparticles for atherosclerosis

被引:0
作者
Jun Chen
Xixi Zhang
Reid Millican
Jacob Emil Creutzmann
Sean Martin
Ho-Wook Jun
机构
[1] University of Alabama at Birmingham,Department of Biomedical Engineering
来源
Nano Convergence | / 7卷
关键词
Atherosclerosis; High-density lipoprotein; Nanoparticles; Therapeutic delivery; Imaging contrast agents; Theranostic agents;
D O I
暂无
中图分类号
学科分类号
摘要
Atherosclerosis is a major contributor to many cardiovascular events, including myocardial infarction, ischemic stroke, and peripheral arterial disease, making it the leading cause of death worldwide. High-density lipoproteins (HDL), also known as “good cholesterol”, have been shown to demonstrate anti-atherosclerotic efficacy through the removal of cholesterol from foam cells in atherosclerotic plaques. Because of the excellent anti-atherosclerotic properties of HDL, in the past several years, there has been tremendous attention in designing HDL mimicking nanoparticles (NPs) of varying functions to image, target, and treat atherosclerosis. In this review, we are summarizing the recent progress in the development of HDL mimicking NPs and their applications for atherosclerosis.
引用
收藏
相关论文
共 50 条
[41]   Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies [J].
Raphaël Duivenvoorden ;
Zahi A. Fayad .
Current Atherosclerosis Reports, 2011, 13 :277-284
[42]   Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis [J].
Farmer, John A. ;
Liao, Joshua .
CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (02) :107-114
[43]   High-density lipoprotein signaling in macrophages and its role in atherosclerosis protection [J].
Trigatti, Bernardo L. .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 :S79-S79
[44]   High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis [J].
Meurs, Illiana ;
Van Eck, Miranda ;
Van Berkel, Theo J. C. .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (13) :1445-1467
[45]   Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis [J].
John A. Farmer ;
Joshua Liao .
Current Atherosclerosis Reports, 2011, 13 :107-114
[46]   Low density lipoprotein (LDL), atherosclerosis and antioxidants [J].
Ryu B.H. .
Biotechnology and Bioprocess Engineering, 2000, 5 (5) :313-319
[47]   Low-density lipoprotein particles in atherosclerosis [J].
Qiao, Ya-Nan ;
Zou, Yan-Li ;
Guo, Shou-Dong .
FRONTIERS IN PHYSIOLOGY, 2022, 13
[48]   High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography [J].
Gordon, Scott M. ;
Chung, Jonathan H. ;
Playford, Martin P. ;
Dey, Amit K. ;
Sviridov, Denis ;
Seifuddin, Fayaz ;
Chen, Yun-Ching ;
Pirooznia, Mehdi ;
Chen, Marcus Y. ;
Mehta, Nehal N. ;
Remaley, Alan T. .
ATHEROSCLEROSIS, 2018, 278 :278-285
[49]   High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study [J].
Josefs, Tatjana ;
Wouters, Kristiaan ;
Tietge, Uwe J. F. ;
Annema, Wijtske ;
Dullaart, Robin P. F. ;
Vaisar, Tomas ;
Arts, Ilja C. W. ;
van der Kallen, Carla J. H. ;
Stehouwer, Coen D. A. ;
Schalkwijk, Casper G. ;
Goldberg, Ira J. ;
Fisher, Edward A. ;
van Greevenbroek, Marleen M. J. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (01) :122-+
[50]   Low-density lipoprotein and oxidised low-density lipoprotein: Their role in the development of atherosclerosis [J].
Hamilton, CA .
PHARMACOLOGY & THERAPEUTICS, 1997, 74 (01) :55-72